Page last updated: 2024-08-25

nodakenin and Reperfusion Injury

nodakenin has been researched along with Reperfusion Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, J; Liao, Y; Lin, X; Tan, R; Wang, L; Zhong, X	1

Other Studies

1 other study(ies) available for nodakenin and Reperfusion Injury

Article	Year
Nodakenin alleviates renal ischaemia-reperfusion injury via inhibiting reactive oxygen species-induced NLRP3 inflammasome activation. Nephrology (Carlton, Vic.), 2021, Volume: 26, Issue:1 Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Disease Models, Animal; Drug Discovery; Glucosides; Inflammasomes; Interleukin-1beta; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha	2021

Article

Year

Nodakenin alleviates renal ischaemia-reperfusion injury via inhibiting reactive oxygen species-induced NLRP3 inflammasome activation.

Nephrology (Carlton, Vic.), 2021, Volume: 26, Issue:1

Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Disease Models, Animal; Drug Discovery; Glucosides; Inflammasomes; Interleukin-1beta; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha

2021